Alessandra Mastropasqua
Overview
Explore the profile of Alessandra Mastropasqua including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
476
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santovito D, Toto L, De Nardis V, Marcantonio P, DAloisio R, Mastropasqua A, et al.
Sci Rep
. 2021 Feb;
11(1):4136.
PMID: 33602976
Diabetic retinopathy (DR) is a leading cause of vision loss and disability. Effective management of DR depends on prompt treatment and would benefit from biomarkers for screening and pre-symptomatic detection...
2.
Mastropasqua L, Perilli R, DAloisio R, Toto L, Mastropasqua A, Donato S, et al.
Ophthalmic Epidemiol
. 2020 Jan;
27(4):237-245.
PMID: 31958252
Purpose: To report on incidental pathological findings met while screening for Diabetic Retinopathy (DR) in Diabetes Clinics (DC) by ophthalmologist-graded digital fundus imaging. Methods: At the DC of Pescara (central...
3.
Mastropasqua L, Silvio Di Staso , DAloisio R, Mastropasqua A, Di Antonio L, Senatore A, et al.
Int J Ophthalmol
. 2019 Oct;
12(10):1589-1597.
PMID: 31637195
Aim: To investigate the efficacy and safety of ranibizumab (RZB group) and dexamethasone implant (DEX group) intravitreal treatments in patients with treatment-naïve center involved diabetic macular edema (DME) by means...
4.
Di Antonio L, Toto L, Mastropasqua A, Brescia L, Erroi E, Lamolinara A, et al.
Sci Rep
. 2018 Oct;
8(1):15631.
PMID: 30353107
The aim of the study was to assess retinal vascular changes using optical coherence tomography angiography (OCTA) and aqueous humour changes of vascular endothelial growth factor (VEGF) and placental growth...
5.
Mastropasqua R, Toto L, Mastropasqua A, Aloia R, De Nicola C, Mattei P, et al.
Int J Ophthalmol
. 2017 Oct;
10(10):1545-1551.
PMID: 29062774
Aim: To investigate foveal avascular zone (FAZ) and parafoveal vessel densities (PRVD) by means of optical coherence tomography angiography (OCTA) in diabetic patients with or without diabetic retinopathy (DR) and...
6.
Mastropasqua R, Fasanella V, Mastropasqua A, Ciancaglini M, Agnifili L
J Ophthalmol
. 2017 May;
2017:7136275.
PMID: 28512580
The ciliary body ablation is still considered as a last resort treatment to reduce the intraocular pressure (IOP) in uncontrolled glaucoma. Several ablation techniques have been proposed over the years,...
7.
Toto L, Curcio C, Mastropasqua A, Mattei P, DUgo E, De Nicola C, et al.
J Cataract Refract Surg
. 2016 Dec;
42(11):1649-1659.
PMID: 27956293
Purpose: To use immunohistochemical staining to evaluate corneal inflammation and apoptosis induced after femtosecond laser incisions or manual incisions. Setting: Ophthalmology Clinic, University G. d'Annunzio, Chieti, Italy. Design: Experimental study....
8.
All laser cataract surgery compared to femtosecond laser phacoemulsification surgery: corneal trauma
Mastropasqua L, Mattei P, Toto L, Mastropasqua A, Vecchiarino L, Falconio G, et al.
Int Ophthalmol
. 2016 Jul;
37(3):475-482.
PMID: 27377068
The aim of this study was to evaluate corneal tissue trauma after femtosecond laser-assisted cataract surgery (FLACS) and phacoemulsification (femtophaco surgery) compared to FLACS and nanolaser emulsification (all laser surgery)....
9.
Lanzini M, Curcio C, Spoerl E, Calienno R, Mastropasqua A, Colasante M, et al.
Int Ophthalmol
. 2016 May;
37(1):235-243.
PMID: 27221268
The aim of this study is to determine modifications in stromal fluorescence intensity after different corneal cross-linking (CXL) procedures and to correlate stromal fluorescence to corneal biomechanical resistance. For confocal...
10.
Agnifili L, Pieragostino D, Mastropasqua A, Fasanella V, Brescia L, Tosi G, et al.
Prog Brain Res
. 2015 Nov;
221:1-32.
PMID: 26518070
Glaucoma, the first cause of irreversible blindness worldwide, is a neurodegenerative disease characterized by the progressive loss of retinal ganglion cells. There are different subtypes of glaucoma, all expression of...